Malassezia pachydermatis is the only species in the genus Malassezia that is classically considered to be zoophilic. This yeast is only occasionally isolated from human skin, although it has been found to cause septic epidemics, especially in neonates. The aim of our study was to investigate the prevalence of M. pachydermatis on the skin of patients with Malassezia-associated diseases and of healthy subjects. One hundred and sixty skin scrapings from patients with pityriasis versicolor (PV), seborrhoeic dermatitis (SD), psoriasis (PS) and healthy individuals, forty each, were inoculated into Sabouraud dextrose agar and into modified Dixon agar. The yeasts isolated were identified according to their macroscopic and microscopic features and physiological properties. M. globosa was the most commonly isolated species in lesional skin of PV (65%) and PS (55%), M. restricta in lesional skin of SD (27.5%), while M. sympodialis was the predominant species recovered from healthy skin, representing 30% of the isolates. Zoophilic species, M. pachydermatis was identified in only one case, from the lesional skin of SD. The results of our study confirm that M. pachydermatis is not a member of the normal human flora and its presence on human skin is rare and indicates transmission from an external source.

Alopecia areata (AA) is a common form of localized, non-scarring hair loss. It is characterized by the loss of hair in patches, total loss of scalp hair (alopecia totalis), or total loss of body hair (alopecia universalis). The etiopathogenesis of the disease is still unclear, but there is evidence that autoimmunity and endocrine dysfunction may be involved. The aim of this study was to determine whether AA is statistically associated with thyroid autoimmunity. In this retrospective epidemiologic study, we compared the frequency of thyroid autoantibodies (thyroglobulin antibody, TgAb, and thyroid peroxidase antibody, TPAb) ATPO) in 70 AA patients and 30 healthy volunteers. Thyroid autoantibodies and thyroid hormones (thyroxine (T4), triiodothyronine (T3) and thyroid stimulating hormone (TSH)) were measured in all subjects. Thyroid functional abnormalities were found in 8 (11.4%) AA patients. Positive autoimmune antibodies were associated with AA in 18 (25.7%) patients, with no significant association between the disease severity and presence of these antibodies. The frequency of thyroid autoantibodies was significantly higher in AA patients than in healthy controls (25.7% vs. 3.3%; p<0.05). Our findings pointed to a significant association between AA and thyroid autoimmunity and showed the tests to detect thyroid autoantibodies to be relevant in AA patients.

Alopecia areata (AA) is disease characterized by focally, nonscaring hair loss on the scalp or any hair-bearing surface. It affects 1-2% population of both genders and occurs at all age groups. The etiology is unknown, although the evidence suggests that AA is a clinical reaction pattern that is the result of combinations of genetic and environmental factors. Effluvium capillorum (EC) is a form of nonscarring diffuse hair shedding. The aim of the study was to determine whether AA is statistically associated with atopy. Sixty patients with AA and 50 patients with EC were enrolled in the study. Presence of atopy was elicited by detailed family and/or personal history of atopy and by intracutaneous tests with the most common atopic allergens. Chi square test was carried out to evaluate statistical significance. 32 (46.7%) of patients with AA were males and 32 (53.3%) females. Majority of them were between 17 and 40 years old. Control group consists of 50 EC patients, 11 (22%) males and 39 (78%) females. Family history of atopy was present in 14 (23.3%) patients with AA, and 6 (12%) with EC (X2=2.37, p>o.05). Evidence of atopy in personal history was present in 16 (26.7%) patients with AA in comparison to control group of 5 (10%) patients, (X2=4.81, p<0.05). Intracoutaneous tests were positive to one or more allergens in 22 (36.7%) with AA compared to 9 (18%) patients with EC (X2=4.70, p<0.05). Based on the family and/or personal history of atopy and intracutaneous tests, we could confirm an atopic constitution in 30% of our AA patients. The frequency of atopy was significantly higher in patients with AA than in controls (30%/10%, X2=6.47, p<0.05). To conclude, our study shows a significant association between AA and atopy.

Alopecia areata (AA) is a heterogeneous disease characterized by nonscarring hair loss on the scalp or any hair-bearing surface. A wide range of clinical presentations can occur, from a single patch of hair loss to complete loss of hair on the scalp (alopecia totalis, AT) or over the entire body (alopecia universalis, AU). The cause of AA is unknown although most evidence supports the hypothesis that AA is an immunologically mediated disease. The aim of the study was to compare serum levels of total immunoglobulin E (IgE) between patients with AA and healthy subjects, and to assess the difference between the localized form and extensive forms of the disease such as AT and AU. Sixty patients with AA and 50 healthy subjects were enrolled in the study. Fifty patients had localized AA (LAA), and ten patients had AT, AU or AT/AU. Serum levels of IgE were measured using fluoroenzyme immunoassay techniques. Serum levels of total IgE were significantly higher in AA patients than in controls (p<0.05). There was no significant difference in serum levels of total IgE between patients with LAA and those with extensive forms of the disease (p>0.05). The exact role of serum IgE in AA should be additionally investigated in future studies.